In a randomized , double-blind , placebo-controlled , three-way cross-over study , @ healthy men received , with an interval of @ h , two oral doses of @ mg lumiracoxib or for comparison , @ mg etoricoxib , for which local tissue accumulation has not been claimed as therapeutic component .